Chromoendoscopy, the use of dyes in the gastrointestinal tract to clarify and distinguish diseased tissue in the prevention of colon cancer, is the subject of this presentation from Anna Buchner, MD. Dr. Buchner provides samples from clinical practice to illustrate the subtypes and macroscopic classification of dysplasia, contrasts random and targeted biopsies during chromoendoscopy and reviews the SCENIC international consensus statement on surveillance and management of dysplasia in IBD.

Related Links

• Barrett’s Esophagus and Esophageal Adenocarcinoma: Diagnosis, Treatment and Ongoing Research at Penn Medicine
• Innovations in IBD Therapy at Penn Medicine
• Dr. Buchner’s Profile